Labcorp Holdings Inc
LH265.640USD
+4.170+1.59%
Fechamento 11/21, 16:00（ET）Cotações atrasadas em 15 min
22.05BValor de mercado
25.78P/L TTM
Mais detalhes de Labcorp Holdings Inc Empresa
Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The Company provides insights and accelerates to improve health and improve lives through its unparalleled diagnostics and drug development capabilities. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
Informações de Labcorp Holdings Inc
Código da empresaLH
Nome da EmpresaLabcorp Holdings Inc
Data de listagemApr 24, 1991
CEOMr. Adam H. Schechter
Número de funcionários70000
Tipo de títulosOrdinary Share
Fim do ano fiscalApr 24
Endereço358 S Main St
CidadeBURLINGTON
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal27215
Telefone13362291127
Sitehttps://www.labcorp.com/
Código da empresaLH
Data de listagemApr 24, 1991
CEOMr. Adam H. Schechter
Executivos da empresa Labcorp Holdings Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Adam H. Schechter
Mr. Adam H. Schechter
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
87.57K
-6.16%
Dr. Brian J. Caveney, M.D., J.D.
Dr. Brian J. Caveney, M.D., J.D.
Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer
Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer
30.07K
-6.24%
Mr. Lance V. Berberian
Mr. Lance V. Berberian
Executive Vice President - Special Advisor, Strategy
Executive Vice President - Special Advisor, Strategy
22.53K
+9.59%
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Independent Director
Independent Director
12.89K
--
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Lead Independent Director
Lead Independent Director
12.84K
--
Ms. Kerrii B. Anderson, CPA
Ms. Kerrii B. Anderson, CPA
Independent Director
Independent Director
8.67K
-31.58%
Ms. Amy B. Summy
Ms. Amy B. Summy
Executive Vice President, Chief Marketing Officer
Executive Vice President, Chief Marketing Officer
5.30K
+16.66%
Mr. Mark S. Schroeder
Mr. Mark S. Schroeder
Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer
Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer
4.96K
--
Mr. Akinbolade Oyegunwa
Mr. Akinbolade Oyegunwa
Executive Vice President and Chief Information and Technology Officer
Executive Vice President and Chief Information and Technology Officer
3.73K
+7.59%
Ms. Megan D. Bailey
Ms. Megan D. Bailey
Executive Vice President and President - Central Laboratories and International
Executive Vice President and President - Central Laboratories and International
3.59K
+5.61%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Adam H. Schechter
Mr. Adam H. Schechter
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
87.57K
-6.16%
Dr. Brian J. Caveney, M.D., J.D.
Dr. Brian J. Caveney, M.D., J.D.
Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer
Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer
30.07K
-6.24%
Mr. Lance V. Berberian
Mr. Lance V. Berberian
Executive Vice President - Special Advisor, Strategy
Executive Vice President - Special Advisor, Strategy
22.53K
+9.59%
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Independent Director
Independent Director
12.89K
--
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Lead Independent Director
Lead Independent Director
12.84K
--
Ms. Kerrii B. Anderson, CPA
Ms. Kerrii B. Anderson, CPA
Independent Director
Independent Director
8.67K
-31.58%
Detalhamento da receita
Moeda: USDAtualizado em: qua, 12 de mar
Moeda: USDAtualizado em: qua, 12 de mar
FY2021
FY2020
FY2019
Os dados relevantes ainda não foram divulgados pela empresa.
Por RegiãoUSD
Nome
Receita
Proporção
Northern America
13.09B
81.22%
Europe
2.05B
12.72%
Other Countries
976.40M
6.06%
Por Empresa
Por Região
Os dados relevantes ainda não foram divulgados pela empresa.
Distribuição de ações
Atualizado em: dom, 16 de nov
Atualizado em: dom, 16 de nov
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
11.79%
BlackRock Institutional Trust Company, N.A.
5.30%
State Street Investment Management (US)
4.62%
Victory Capital Management Inc.
3.18%
Geode Capital Management, L.L.C.
2.56%
Outro
72.54%
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
11.79%
BlackRock Institutional Trust Company, N.A.
5.30%
State Street Investment Management (US)
4.62%
Victory Capital Management Inc.
3.18%
Geode Capital Management, L.L.C.
2.56%
Outro
72.54%
Tipos de investidores
Investidores
Proporção
Investment Advisor
50.29%
Investment Advisor/Hedge Fund
38.90%
Research Firm
2.40%
Pension Fund
1.76%
Hedge Fund
1.60%
Bank and Trust
1.56%
Sovereign Wealth Fund
1.25%
Individual Investor
0.37%
Family Office
0.26%
Outro
1.61%
Participação acionária institucional
Atualizado em: qua, 1 de out
Atualizado em: qua, 1 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
1802
83.09M
100.23%
+765.81K
2025Q2
1825
81.46M
98.03%
-5.42M
2025Q1
1872
81.69M
97.58%
-5.17M
2024Q4
1872
81.10M
96.90%
-5.32M
2024Q3
1856
80.09M
95.55%
-6.82M
2024Q2
1876
81.29M
96.43%
-7.49M
2024Q1
1904
82.39M
97.73%
-8.65M
2023Q4
1947
83.11M
99.02%
-9.76M
2023Q3
1930
84.34M
99.29%
-7.18M
2023Q2
1934
84.05M
94.75%
-3.56M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
The Vanguard Group, Inc.
9.84M
11.84%
+155.62K
+1.61%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
4.40M
5.3%
-203.29K
-4.41%
Jun 30, 2025
State Street Investment Management (US)
3.86M
4.65%
+36.00K
+0.94%
Jun 30, 2025
Victory Capital Management Inc.
2.20M
2.64%
+2.14M
+3588.62%
Jun 30, 2025
Geode Capital Management, L.L.C.
2.11M
2.54%
+44.63K
+2.16%
Jun 30, 2025
Wellington Management Company, LLP
1.82M
2.19%
+1.55M
+584.94%
Jun 30, 2025
Allspring Global Investments, LLC
2.00M
2.41%
+43.51K
+2.22%
Jun 30, 2025
Select Equity Group, L.P.
2.13M
2.57%
-87.26K
-3.93%
Jun 30, 2025
Diamond Hill Capital Management Inc.
1.82M
2.19%
-128.08K
-6.56%
Jun 30, 2025
Nordea Funds Oy
1.83M
2.2%
+401.81K
+28.15%
Jun 30, 2025
Ver Mais
ETFs Relacionados
Atualizado em: qui, 6 de nov
Atualizado em: qui, 6 de nov
Nome
Proporção
iShares U.S. Healthcare Providers ETF
3.89%
Knowledge Leaders Developed World ETF
3.18%
Thrivent Small-Mid Cap ESG ETF
2.26%
SPDR S&P Health Care Services ETF
2%
Brandes US Value ETF
1.75%
Invesco S&P 500 Equal Weight Health Care ETF
1.73%
Madison Covered Call ETF
1.69%
Nuveen ESG Mid-Cap Value ETF
1.57%
Schwab Ariel Opportunities ETF
1.49%
iShares ESG Aware MSCI USA Value ETF
1.43%
Ver Mais
iShares U.S. Healthcare Providers ETF
Proporção3.89%
Knowledge Leaders Developed World ETF
Proporção3.18%
Thrivent Small-Mid Cap ESG ETF
Proporção2.26%
SPDR S&P Health Care Services ETF
Proporção2%
Brandes US Value ETF
Proporção1.75%
Invesco S&P 500 Equal Weight Health Care ETF
Proporção1.73%
Madison Covered Call ETF
Proporção1.69%
Nuveen ESG Mid-Cap Value ETF
Proporção1.57%
Schwab Ariel Opportunities ETF
Proporção1.49%
iShares ESG Aware MSCI USA Value ETF
Proporção1.43%
Dividendo
Um total de
692.30M
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Jan 09, 2025
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Mar 12, 2025 going ex on Feb 27, 2025
Feb 27, 2025
Mar 12, 2025
Feb 27, 2025
Oct 10, 2024
LH.NB Final Cash Dividend of gross USD 0.72 paid on Dec 13, 2024 going ex on Nov 26, 2024
Nov 26, 2024
Dec 13, 2024
Nov 26, 2024
Jul 25, 2024
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Sep 13, 2024 going ex on Aug 29, 2024
Aug 29, 2024
Sep 13, 2024
Aug 29, 2024
Apr 11, 2024
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Jun 12, 2024 going ex on May 24, 2024
May 28, 2024
Jun 12, 2024
May 24, 2024
Jan 12, 2024
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Mar 13, 2024 going ex on Feb 26, 2024
Feb 27, 2024
Mar 13, 2024
Feb 26, 2024
Oct 12, 2023
LH.NB Final Cash Dividend of gross USD 0.72 paid on Dec 12, 2023 going ex on Nov 07, 2023
Nov 08, 2023
Dec 12, 2023
Nov 07, 2023
Jul 13, 2023
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Sep 08, 2023 going ex on Aug 07, 2023
Aug 08, 2023
Sep 08, 2023
Aug 07, 2023
Apr 06, 2023
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Jun 08, 2023 going ex on May 17, 2023
May 18, 2023
Jun 08, 2023
May 17, 2023
Jan 12, 2023
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Mar 13, 2023 going ex on Feb 22, 2023
Feb 23, 2023
Mar 13, 2023
Feb 22, 2023
Oct 12, 2022
LH.NB Final Cash Dividend of gross USD 0.72 paid on Dec 09, 2022 going ex on Nov 16, 2022
Nov 17, 2022
Dec 09, 2022
Nov 16, 2022
Ver Mais
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
Perguntas frequentes
Quem são os cinco principais acionistas de Labcorp Holdings Inc?
Os cinco principais acionistas de Labcorp Holdings Inc são:
The Vanguard Group, Inc. detém 9.84M Ações, representando 11.84% do total de Ações.
BlackRock Institutional Trust Company, N.A. detém 4.40M Ações, representando 5.30% do total de Ações.
State Street Investment Management (US) detém 3.86M Ações, representando 4.65% do total de Ações.
Victory Capital Management Inc. detém 2.20M Ações, representando 2.64% do total de Ações.
Geode Capital Management, L.L.C. detém 2.11M Ações, representando 2.54% do total de Ações.
The Vanguard Group, Inc. detém 9.84M Ações, representando 11.84% do total de Ações.
BlackRock Institutional Trust Company, N.A. detém 4.40M Ações, representando 5.30% do total de Ações.
State Street Investment Management (US) detém 3.86M Ações, representando 4.65% do total de Ações.
Victory Capital Management Inc. detém 2.20M Ações, representando 2.64% do total de Ações.
Geode Capital Management, L.L.C. detém 2.11M Ações, representando 2.54% do total de Ações.
Quais são os três principais tipos de acionistas de Labcorp Holdings Inc?
Os três principais tipos de acionistas da Labcorp Holdings Inc são:
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
Quantas instituições possuem ações da Labcorp Holdings Inc (LH)?
Em 2025Q3, 1802 instituições possuíam ações da Labcorp Holdings Inc, com valor de mercado aproximado de 83.09M, representando 100.23% do total de ações. Em comparação com 2025Q2, a participação institucional aumentou em 2.20%.
Qual é a maior fonte de receita da Labcorp Holdings Inc?
Em FY2021, o segmento de negócios -- gerou a maior receita para Labcorp Holdings Inc, totalizando -- e representando --% da receita total.
